Jiaxing Zhu

机构：Zunyi Medical University, Zhengzhou University · ORCID：0000-0001-6143-5807

发表论文 58 篇 · 总被引 496 次 · h-index 15

代表论文

• Pretransplant use of immune checkpoint inhibitors for hepatocellular carcinoma: A multicenter, retrospective cohort study (2024 · American Journal of Transplantation · 被引 61)
• SLC26A9 promotes colorectal tumorigenesis by modulating Wnt/β-catenin signaling (2024 · Cell Death Discovery · 被引 19)
• A potential tumor marker: Chaperonin containing TCP‑1 controls the development of malignant tumors (Review) (2023 · International Journal of Oncology · 被引 19)
• Pathophysiological role of ion channels and transporters in hepatocellular carcinoma (2024 · Cancer Gene Therapy · 被引 14)
• Immune biomarkers in circulating cells of NSCLC patients can effectively evaluate the efficacy of chemotherapy combined with anti-PD-1 therapy (2025 · Frontiers in Immunology · 被引 11)
• Development and validation of a novel prognostic model to predict 1-year post-transplant mortality for acute-on-chronic hepatitis B liver failure: a nationwide, multicentre, cohort study (2025 · EClinicalMedicine · 被引 9)